64 related articles for article (PubMed ID: 18497971)
1. A cyclic peptide derived from alpha-fetoprotein inhibits the proliferative effects of the epidermal growth factor and estradiol in MCF7 cells.
Torres C; Antileo E; Epuñán MJ; Pino AM; Valladares LE; Sierralta WD
Oncol Rep; 2008 Jun; 19(6):1597-603. PubMed ID: 18497971
[TBL] [Abstract][Full Text] [Related]
2. A peptide derived from alpha-fetoprotein inhibits the proliferation induced by estradiol in mammary tumor cells in culture.
Sierralta WD; Epuñan MJ; Reyes JM; Valladares LE; Andersen TT; Bennett JA; Jacobson HI; Pino AM
Oncol Rep; 2008 Jan; 19(1):229-35. PubMed ID: 18097600
[TBL] [Abstract][Full Text] [Related]
3. The effect of progesterone, testosterone and synthetic progestogens on growth factor- and estradiol-treated human cancerous and benign breast cells.
Krämer EA; Seeger H; Krämer B; Wallwiener D; Mueck AO
Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):77-83. PubMed ID: 16460873
[TBL] [Abstract][Full Text] [Related]
4. A cyclized peptide derived from alpha fetoprotein inhibits the proliferation of ER-positive canine mammary cancer cells.
Torres CG; Pino AM; Sierralta WD
Oncol Rep; 2009 Jun; 21(6):1397-404. PubMed ID: 19424616
[TBL] [Abstract][Full Text] [Related]
5. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
Pedersen NM; Breen K; Rødland MS; Haslekås C; Stang E; Madshus IH
Mol Cancer Res; 2009 Feb; 7(2):275-84. PubMed ID: 19208749
[TBL] [Abstract][Full Text] [Related]
6. Synthetic peptide derived from alpha-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization.
DeFreest LA; Mesfin FB; Joseph L; McLeod DJ; Stallmer A; Reddy S; Balulad SS; Jacobson HI; Andersen TT; Bennett JA
J Pept Res; 2004 May; 63(5):409-19. PubMed ID: 15140158
[TBL] [Abstract][Full Text] [Related]
7. Prevention of N-methyl-N-nitrosourea-induced breast cancer by alpha-fetoprotein (AFP)-derived peptide, a peptide derived from the active site of AFP.
Parikh RR; Gildener-Leapman N; Narendran A; Lin HY; Lemanski N; Bennett JA; Jacobson HI; Andersen TT
Clin Cancer Res; 2005 Dec; 11(23):8512-20. PubMed ID: 16322315
[TBL] [Abstract][Full Text] [Related]
8. HDAC inhibitor SNDX-275 induces apoptosis in erbB2-overexpressing breast cancer cells via down-regulation of erbB3 expression.
Huang X; Gao L; Wang S; Lee CK; Ordentlich P; Liu B
Cancer Res; 2009 Nov; 69(21):8403-11. PubMed ID: 19826038
[TBL] [Abstract][Full Text] [Related]
9. Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis.
Seeger H; Wallwiener D; Mueck AO
Gynecol Endocrinol; 2008 Oct; 24(10):576-9. PubMed ID: 19012101
[TBL] [Abstract][Full Text] [Related]
10. TOB1 is regulated by EGF-dependent HER2 and EGFR signaling, is highly phosphorylated, and indicates poor prognosis in node-negative breast cancer.
Helms MW; Kemming D; Contag CH; Pospisil H; Bartkowiak K; Wang A; Chang SY; Buerger H; Brandt BH
Cancer Res; 2009 Jun; 69(12):5049-56. PubMed ID: 19491269
[TBL] [Abstract][Full Text] [Related]
11. A synthetic peptide derived from alpha-fetoprotein inhibits the estradiol-induced proliferation of mammary tumor cells in culture through the modulation of p21.
Sierralta WD; Epuñan MJ; Reyes JM; Valladares LE; Pino AM
Adv Exp Med Biol; 2008; 617():463-8. PubMed ID: 18497070
[TBL] [Abstract][Full Text] [Related]
12. A mathematical model for the effects of HER2 overexpression on cell proliferation in breast cancer.
Eladdadi A; Isaacson D
Bull Math Biol; 2008 Aug; 70(6):1707-29. PubMed ID: 18648887
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of paclitaxel conjugated with an ErbB2-recognizing peptide, EC-1.
Li P; Jiang S; Pero SC; Oligino L; Krag DN; Michejda CJ; Roller PP
Biopolymers; 2007 Nov; 87(4):225-30. PubMed ID: 17879382
[TBL] [Abstract][Full Text] [Related]
14. Cell type dependent endocytic internalization of ErbB2 with an artificial peptide ligand that binds to ErbB2.
Hashizume T; Fukuda T; Nagaoka T; Tada H; Yamada H; Watanabe K; Salomon DS; Seno M
Cell Biol Int; 2008 Jul; 32(7):814-26. PubMed ID: 18442934
[TBL] [Abstract][Full Text] [Related]
15. Procollagen I COOH-terminal fragment induces VEGF-A and CXCR4 expression in breast carcinoma cells.
Palmieri D; Astigiano S; Barbieri O; Ferrari N; Marchisio S; Ulivi V; Volta C; Manduca P
Exp Cell Res; 2008 Jul; 314(11-12):2289-98. PubMed ID: 18570923
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E1 and misoprostol increase epidermal growth factor production in 3D-cultured human annulus cells.
Gruber HE; Hoelscher G; Loeffler B; Chow Y; Ingram JA; Halligan W; Hanley EN
Spine J; 2009 Sep; 9(9):760-6. PubMed ID: 19535298
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha-stimulated membrane type 1-matrix metalloproteinase production is modulated by epidermal growth factor receptor signaling in human gingival fibroblasts.
Smith PC; Guerrero J; Tobar N; Cáceres M; González MJ; Martínez J
J Periodontal Res; 2009 Feb; 44(1):73-80. PubMed ID: 19515020
[TBL] [Abstract][Full Text] [Related]
18. The role of peroxisome proliferator-activated receptor-beta/delta in epidermal growth factor-induced HaCaT cell proliferation.
Liang P; Jiang B; Yang X; Xiao X; Huang X; Long J; Zhang P; Zhang M; Xiao M; Xie T; Huang X
Exp Cell Res; 2008 Oct; 314(17):3142-51. PubMed ID: 18625220
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor (TNF) receptor-2-mediated DNA synthesis and proliferation in primary cultures of adult rat hepatocytes: The involvement of endogenous transforming growth factor-alpha.
Okamoto H; Kimura M; Watanabe N; Ogihara M
Eur J Pharmacol; 2009 Feb; 604(1-3):12-9. PubMed ID: 19100731
[TBL] [Abstract][Full Text] [Related]
20. Hormones of pregnancy, alpha-feto protein, and reduction of breast cancer risk.
Jacobson HI; Lemanski N; Narendran A; Agarwal A; Bennett JA; Andersen TT
Adv Exp Med Biol; 2008; 617():477-84. PubMed ID: 18497072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
